Clinical Trial: Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Open-Label Safety and Immunogenicity Trial of MPV/S-2P, a Next Generation SARS-CoV-2 Booster Vaccine, in Previously Vaccinated Adults
Brief Summary:
A clinical trial to evaluate the safety, reactogenicity, and immunogenicity of MPV/S-2P administered intranasally to adults who have previously received a primary series and at least one booster with an authorized or licensed mRNA SARS-CoV-2 parenteral vaccine.The primary objective is to evaluate the safety and reactogenicity of a single dose of MPV/S-2P in previously vaccinated healthy adults.
Read more